1-2 of 2
Keywords: Secondary prevention of stroke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Triflusal and Aspirin in the Secondary Prevention of Atherothrombotic Ischemic Stroke: A Very Long-Term Follow-Up

Subject Area:
Cardiovascular System , Neurology and Neuroscience
José Alvarez-Sabín, Manuel Quintana, Estevo Santamarina, Olga Maisterra
Journal: Cerebrovascular Diseases
Cerebrovasc Dis (2014) 37 (3): 181–187.
https://doi.org/10.1159/000357662
Published Online: 05 February 2014
... acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13. 33. Bergamasco B, Benna P, Carolei A, Rasura M, Rudelli G, Fieschi C: A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen...
View article titled, Triflusal and Aspirin in the Secondary Prevention of Atherothrombotic Ischemic Stroke: A Very Long-Term Follow-Up
Open the PDF for Triflusal and Aspirin in the Secondary Prevention of Atherothrombotic Ischemic Stroke: A Very Long-Term Follow-Up in another window
Journal Articles

A Randomized, ASA-Controlled Trial of Mesoglycan in Secondary Prevention after Cerebral Ischemic Events

Subject Area:
Cardiovascular System , Neurology and Neuroscience
Sandro Forconi, Noè Battistini, Maurizio Guerrini, Stefano Giacomo Passero
Journal: Cerebrovascular Diseases
Cerebrovasc Dis (1995) 5 (5): 334–341.
https://doi.org/10.1159/000107878
Published Online: 28 August 1995
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Mesoglycan Glycosaminoglycans Acetylsalicylic acid Antithrombotic agents Secondary prevention of stroke 28 8 1995 Original Paper Cerebrovasc Dis 1995;5:334-341 Sandro...
View article titled, A Randomized, ASA-Controlled Trial of Mesoglycan in Secondary Prevention after Cerebral Ischemic Events
Open the PDF for A Randomized, ASA-Controlled Trial of Mesoglycan in Secondary Prevention after Cerebral Ischemic Events in another window